SCHEMBL20069744

SCHEMBL20069744

Cc1ccc(F)cc1C(=O)NC1(C)CN(C)C1

nearest known ligand 0.45

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RET P07949 15/20 0.45
CXCR5 P32302 4/20 0.38
HDAC4 P56524 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20069741 0.90 RET (0.46) RET
SCHEMBL20068931 0.86 RET (0.47) RET
SCHEMBL20147546 0.85 RET (0.40) RETCXCR5HDAC4
SCHEMBL20147554 0.80 RET (0.45) RET
SCHEMBL20152062 0.79 RET (0.42) RET
SCHEMBL21651991 0.78 CCR3 (0.49) RET
SCHEMBL20147539 0.78 RET (0.46) RET
SCHEMBL20069762 0.76 CCR3 (0.44) RETHDAC4
SCHEMBL20069671 0.75 RET (0.52) RETHDAC4
SCHEMBL20068927 0.74 CCR3 (0.45) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018071454-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed